Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.

ABSTRACT: Little is known about the effect of evolving risk-based cervical cancer screening and management guidelines on United States (US) clinical practice and patient outcomes. We describe the National Cancer Institute's Population-based Research Optimizing Screening through Personalized Regimens (PROSPR I) consortium, methods and baseline findings from its cervical sites: Kaiser Permanente Washington, Kaiser Permanente Northern California, Kaiser Permanente Southern California, Parkland Health & Hospital System/University of Texas Southwestern (Parkland-UTSW) and New Mexico HPV Pap Registry housed by University of New Mexico (UNM-NMHPVPR). Across these diverse healthcare settings, we collected data on human papillomavirus (HPV) vaccinations, screening tests/results, diagnostic and treatment proc

SUBMITTER: Kamineni A 

PROVIDER: S-EPMC6941787 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature